Related references
Note: Only part of the references are listed.A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma
Irene Tsung et al.
ONCOLOGIST (2021)
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
Alexandre el Hage et al.
CANCERS (2021)
Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review
Juliya Fisher et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review
Thibaut D'Izarny-Gargas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
Alexander J. Stratigos et al.
EUROPEAN JOURNAL OF CANCER (2020)
The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature
Vivek Kumar et al.
ONCOLOGIST (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
Rossana Franzin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
Pauline De Bruyn et al.
CURRENT OPINION IN ONCOLOGY (2019)
Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
Hung-Chih Lai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results
Jacques Dantal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine
Wai H. Lim et al.
KIDNEY INTERNATIONAL (2017)
Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma
Brianna N. Harris et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
A Multi-Institutional Comparison of Outcomes of Immunosuppressed and Immunocompetent Patients Treated With Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
Bindu V. Manyam et al.
CANCER (2017)
Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma A 10-Year, Single-Institution Cohort Study
Chrysalyne D. Schmults et al.
JAMA DERMATOLOGY (2013)
Share Paper
